BlackRock Health Sciences Trust (BME)

NEW YORK--(BUSINESS WIRE)---- $BBN--Today, BlackRock Resources & Commodities Strategy Trust (NYSE: BCX), BlackRock Enhanced Equity Dividend Trust (NYSE: BDJ), BlackRock Energy and Resources Trust (NYSE: BGR), BlackRock Enhanced International Dividend Trust (NYSE: BGY), BlackRock Health Sciences Trust (NYSE: BME), BlackRock Health Sciences Term Trust (NYSE: BMEZ), BlackRock Enhanced Global Dividend Trust (NYSE: BOE), BlackRock Utilities, Infrastructure & Power Opportunities Trust (NYSE: BUI), Bla.

B&M European Value Retail SA (LSE:BME) is being judged from two angles by the City, with Deutsche Bank turning more cautious on the cost of its turnaround while Shore Capital argues the risks are already priced in. Deutsche has cut its price target to 175p from 180p and reiterated its 'hold' rating, leaving the shares trading close to fair value after their recent recovery.

The abrdn Healthcare Opportunities Fund has delivered strong historical returns but now faces sustainability concerns due to leverage, premium to NAV, and likely fee waiver expiration. THQ's 11% yield is increasingly funded by return of capital, with NAV erosion and potential distribution cuts on the horizon. BlackRock Health Sciences Trust offers a safer alternative: a 7.5% yield, a conservative distribution policy, no leverage, a lower expense ratio, and currently trades at a 5.6% discount to NAV.

Shares in B&M European Value Retail SA (LSE:BME) fell 2% in early trading after a third profits warning in four months, but pared losses as analysts said management appeared to be making progress in the turnaround. The third-quarter trading update, covering the 13 weeks to 27 December, revealed that group sales increased 2.9%, driven by contributions from new space, partly offset by a 0.6% decline in UK like-for-likes.

B&M European Value Retail SA (LSE:BME) has issued its third profit warning since last summer as the discounter's rejigged board struggles to turn around performance. The discount retailer now expects adjusted EBITDA for the year to March of £440-475 million, down from previous guidance of £470-520 million, due to investments in pricing, stock clearance of discontinued lines, and the financial underperformance of Heron Foods.

BARCELONA, Spain--(BUSINESS WIRE)--eDreams ODIGEO (EDR:BME) (the ‘Company' or ‘eDO'), the world's leading travel subscription company, today announces the strategic scaling of its Prime subscription service into the rail sector. This marks the latest step in creating the world's most comprehensive AI-powered travel subscription platform, further diversifying its revenue streams and enhancing the lifetime value (LTV) of its subscriber base. Unlocking a significant market opportunity The European.

NEW YORK--(BUSINESS WIRE)---- $BBN--Today, BlackRock Resources & Commodities Strategy Trust (NYSE: BCX), BlackRock Enhanced Equity Dividend Trust (NYSE: BDJ), BlackRock Energy and Resources Trust (NYSE: BGR), BlackRock Enhanced International Dividend Trust (NYSE: BGY), BlackRock Health Sciences Trust (NYSE: BME), BlackRock Health Sciences Term Trust (NYSE: BMEZ), BlackRock Enhanced Global Dividend Trust (NYSE: BOE), BlackRock Utilities, Infrastructure & Power Opportunities Trust (NYSE: BUI), Bla.

BlackRock Health Sciences Trust has seen some strong performance recently, yet still trades at a -7.8% discount to NAV, offering compelling value. BME removed its options-writing strategy, eliminating upside caps and shifting focus to long-term capital appreciation in health sciences equities. Despite sector volatility and UNH headwinds, BME remains diversified in healthcare exposure, but some concentration in top holdings like LLY.

I rate BlackRock Health Sciences Trust a Buy for income-focused investors seeking long-term, buy-and-hold exposure to blue-chip healthcare stocks. BME trades at a -7.8% discount to NAV and offers a monthly distribution yielding approximately 8%, supported by consistent, rising dividends. Recent political pressure on healthcare has depressed valuations, but I expect portfolio holdings like Eli Lilly and UnitedHealth to rebound as regulatory focus wanes.

NEW YORK--(BUSINESS WIRE)--Today, BlackRock Resources & Commodities Strategy Trust (NYSE: BCX), BlackRock Enhanced Equity Dividend Trust (NYSE: BDJ), BlackRock Energy and Resources Trust (NYSE: BGR), BlackRock Enhanced International Dividend Trust (NYSE: BGY), BlackRock Health Sciences Trust (NYSE: BME), BlackRock Health Sciences Term Trust (NYSE: BMEZ), BlackRock Enhanced Global Dividend Trust (NYSE: BOE), BlackRock Utilities, Infrastructure & Power Opportunities Trust (NYSE: BUI), BlackRock Enhanced Large Cap Core Fund, Inc. (NYSE: CII), BlackRock Science and Technology Trust (NYSE: BST), BlackRock Science and Technology Term Trust (NYSE: BSTZ), BlackRock Technology and Private Equity Term Trust (NYSE: BTX), BlackRock Capital Allocation Term Trust (NYSE: BCAT), and BlackRock ESG Capital Allocation Term Trust (NYSE: ECAT) (collectively, the “Funds”) paid the following distributions per share

The broader equity indexes continue to look strong, led by mega-cap tech, which has helped push the markets to all-time highs. With hitting new all-time highs, I continue to allow my cash pile to build up instead of putting it all to work at what looks like elevated levels. That said, I make some purchases every month to help grow cash flow over time and to capitalize on pockets of opportunity.

Analysts struck a cautious but mildly constructive tone on B&M European Value Retail SA (LSE:BME) following its interim results, which confirmed a sharp year-on-year drop in profit but few surprises after two earlier pre-releases. The discount retailer posted first-half EBITDA of £191 million, down 30% year on year, on sales of £2.75 billion, up 4%.

NEW YORK--(BUSINESS WIRE)--Today, BlackRock Resources & Commodities Strategy Trust (NYSE: BCX), BlackRock Enhanced Equity Dividend Trust (NYSE: BDJ), BlackRock Energy and Resources Trust (NYSE: BGR), BlackRock Enhanced International Dividend Trust (NYSE: BGY), BlackRock Health Sciences Trust (NYSE: BME), BlackRock Health Sciences Term Trust (NYSE: BMEZ), BlackRock Enhanced Global Dividend Trust (NYSE: BOE), BlackRock Utilities, Infrastructure & Power Opportunities Trust (NYSE: BUI), Bla.

B&M European Value Retail's (LSE:BME) second profit warning in as many weeks "erodes trust further", said analysts, with some saying it demands more questions than it answers.  Deutsche Bank said the discounter is "facing a credibility crisis", after Monday's guidance downgrade came less than two weeks after a new 'Back to Basics' strategy was published.

Shares in B&M European Value Retail SA (LSE:BME) dropped 15% to 185p in early trading on Monday after the discount retailer cut its full-year profit guidance and announced the departure of its chief financial officer. The company said an internal review had uncovered around £7 million of overseas freight costs that were not properly recorded earlier in the year due to a systems update.

The half-year update from B&M European Value Retail SA (LSE:BME) produced mainly disappointment from analysts and investors, though there was a sliver of hope about a turnaround plan announced by new CEO Tjeerd Jegen. Second-quarter UK like-for-like sales fell 1.1%, a sharp slowdown from the 1.3% growth in the first quarter that was, noted Jefferies' Andrew Wade, boosted by Easter and weather effects.